ONCOVERA
Live / Applied — New application — not yet assigned to an examiner (as of 02 Nov 2026)
What this means for you
Not registered yet, but its 02 Nov 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50194334
- Mark type
- Word mark
- Filed
- 02 Nov 2026
- Attorney of record
- Steven D. Lustig
Goods and services
- Class 041 — Education and entertainment services: Educational services, namely, providing online non-downloadable educational materials in the fields of oncology, cancer care, precision medicine, cancer screening, treatment options, survivorship, nutrition, exercise, and wellness; educational services, namely, conducting webinars, workshops, and presentations in the fields of cancer research, precision oncology, diagnostics, and emerging therapeutic approaches
- Class 042 — Scientific and technological services: Scientific research and development; pharmaceutical research and development; biochemical research and development; vaccine research and development; research and development of medicines; research and development in the pharmaceutical and biotechnology fields; research and development in the fields of biochemistry and biotechnology; research and development of personalized cancer vaccines and immunotherapies, including mRNA-based vaccines; preclinical evaluation of vaccines and immunotherapies; scientific research involving tumor sequencing, neoantigen identification, immune profiling, tumor antigen presentation, and therapeutic immune responses; laboratory research and development services relating to anticancer pharmaceutical compounds and therapeutic agents, including drug discovery, screening and testing of pharmaceutical compounds, cell culture and molecular biology research, and development and preclinical evaluation of potential cancer treatments; computational drug discovery and research into G-protein-coupled receptors and receptor signaling for the development of cancer therapeutics; research and development in the fields of translational research, biomarker discovery, multi-omic analysis, computational biology, and AI-enabled tools for integrating and analyzing clinical and molecular information; research and development of cancer diagnostic technologies involving circulating tumor DNA and RNA, circulating tumor cells, extracellular vesicles, proteomics, genomic sequencing, and multi-omic biomarker analysis; research and development of computational and artificial intelligence tools for cancer detection, disease monitoring, prediction of treatment response, and identification of therapeutic targets; software as a service featuring software for organizing, analyzing, and displaying medical, genomic, laboratory, imaging, clinical trial, and treatment information in the fields of oncology, cancer care, precision medicine, and healthcare decision support; medical and scientific research in the field of cancer treatment and diagnosis; biological research and analysis; computational biology research; research in the field of bioinformatics; scientific research in the field of genetics; providing medical research and scientific research information in the field of oncology via the internet
- Class 044 — Medical, beauty and agricultural services: Providing healthcare information and medical information in the fields of oncology, cancer care, precision medicine, cancer screening, cancer diagnostics, treatment options, survivorship, clinical trials, disease monitoring, and patient navigation; providing individualized medical diagnostic information; patient navigation services in the field of cancer care; medical diagnostic testing services, including biomarker testing and clinical laboratory diagnostic services
Owner
- Oncovera, LLC, Reston, VA, US
Prosecution history
- 02 Nov 2026 — APPLICATION FILING RECEIPT MAILED
- 02 Nov 2026 — NEW APPLICATION ENTERED